[NRIX] QoQ Quarter Result on 30-Nov-2023 [#Q4]

Stock
[NRIX] Nurix Therapeutics, Inc.
Announcement Date
15-Feb-2024
Financial Year
2023
Quarter
30-Nov-2023 [#Q4]
Profit Trend
QoQ- -13.45%
YoY- -0.60%
Quarter Report
NRIX's Result
NRIX's Financial Summary
View:
Show?
Quarter Result
31/08/24 31/05/24 29/02/24 30/11/23 31/08/23 31/05/23 28/02/23 CAGR
Revenue 12,588 12,092 16,585 15,159 18,467 30,676 12,685 -0.50%
PBT -48,874 -44,456 -41,428 -41,956 -36,982 -24,277 -40,733 12.85%
Tax 82 90 90 7,887 3,424 -2,488 -5,399 -
NP -48,956 -44,546 -41,518 -41,956 -36,982 -21,789 -35,334 24.15%
Tax Rate - - - - - - - -
Total Cost 61,544 56,638 58,103 57,115 55,449 52,465 48,019 17.90%
Ratio Analysis
31/08/24 31/05/24 29/02/24 30/11/23 31/08/23 31/05/23 28/02/23 CAGR
NP Margin -388.91 -368.39 -250.33 -276.77 -200.26 -71.03 -278.55 24.79%
Per Share
31/08/24 31/05/24 29/02/24 30/11/23 31/08/23 31/05/23 28/02/23 CAGR
EPS -0.67 -0.71 -0.76 -0.77 -0.68 -0.40 -0.65 2.03%
EPS Diluted -0.67 -0.71 -0.76 -0.77 -0.68 -0.40 -0.65 2.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.